↓ Skip to main content

Cochrane Database of Systematic Reviews

Interleukin 2 receptor antagonists for kidney transplant recipients

Overview of attention for article published in Cochrane database of systematic reviews, January 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

blogs
1 blog
twitter
1 tweeter

Citations

dimensions_citation
177 Dimensions

Readers on

mendeley
160 Mendeley
citeulike
3 CiteULike
Title
Interleukin 2 receptor antagonists for kidney transplant recipients
Published in
Cochrane database of systematic reviews, January 2010
DOI 10.1002/14651858.cd003897.pub3
Pubmed ID
Authors

Angela C Webster, Lorenn P Ruster, Richard G McGee, Sandra L Matheson, Gail Y Higgins, Narelle S Willis, Jeremy R Chapman, Jonathan C Craig

Abstract

Interleukin 2 receptor antagonists (IL2Ra) are used as induction therapy for prophylaxis against acute rejection in kidney transplant recipients. Use of IL2Ra has increased steadily since their introduction, but the proportion of new transplant recipients receiving IL2Ra differs around the globe, with 27% of new kidney transplant recipients in the United States, and 70% in Australasia receiving IL2Ra in 2007.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 2 1%
India 1 <1%
Australia 1 <1%
Indonesia 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Denmark 1 <1%
United States 1 <1%
Unknown 151 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 29 18%
Student > Ph. D. Student 22 14%
Other 19 12%
Student > Bachelor 18 11%
Student > Postgraduate 14 9%
Other 36 23%
Unknown 22 14%
Readers by discipline Count As %
Medicine and Dentistry 90 56%
Nursing and Health Professions 8 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Computer Science 4 3%
Agricultural and Biological Sciences 4 3%
Other 14 9%
Unknown 35 22%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 May 2014.
All research outputs
#1,764,388
of 12,527,093 outputs
Outputs from Cochrane database of systematic reviews
#3,939
of 8,923 outputs
Outputs of similar age
#21,727
of 146,118 outputs
Outputs of similar age from Cochrane database of systematic reviews
#44
of 115 outputs
Altmetric has tracked 12,527,093 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,923 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.2. This one has gotten more attention than average, scoring higher than 58% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 146,118 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 115 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 61% of its contemporaries.